TMO · Thermo Fisher Scientific Inc

Back to holdings

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases.

Close · 3M

+3.19%

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals1

Win rate100% (1/1)

Avg buy return+6.52%

PQUSno longer held3 signals

PQUS · Exit · 1d

The weight history for TMO in PQUS reveals a sudden, complete divestment on July 17, 2026, following a consistent 0.0800% holding for the preceding week. This abrupt removal is consistent with Pictet Asset Management's periodic rebalancing and measured turnover strategy, where the AI ranking system initiated a definitive action. At a current price of $543.19 and sitting at 85% of its 52-week high, TMO’s significant 14.6% return over 30 days, alongside a PER of 28.55 and revenue growth of 5.36%, likely prompted the AI to re-evaluate its ranking. The system’s layered concentration and sector-balance rules may have then dictated the full removal of TMO from the ~165 US large-cap portfolio during a rebalance cycle.

weight 0.080% → 0 (exited)·stock up 12.7% in the 30 days before

Jul 17·entry $532.48·now $526.23

-1.17%

since Jul 17

PQUS · Weight decrease · 2d

Thermo Fisher Scientific's financial profile, featuring a PER of 25.65 and a PBR of 4.08 alongside 5.36% revenue growth and a 13.24% ROE, places it within the US large-cap universe that PQUS targets. These metrics suggest a moderately growing and profitable company. The AI ranking system employed by Pictet Asset Management likely assessed these figures against other large-cap health care names, potentially finding TMO's valuation less compelling given its recent performance. The consecutive weight decrease for TMO from 0.1800% on June 11 to 0.1000% by June 13 directly followed a period where the stock had registered a -17.0% 90-day return, despite its flat 30-day performance leading up to this rebalance. This adjustment, executed during a periodic rebalance within PQUS's approximately 165 holdings, reflects the AI's re-evaluation of TMO's position to maintain sector-balance and concentration rules within the portfolio.

weight 0.180% → 0.100% (-0.080 pp)·stock up 5.2% in the 30 days before

Jun 13·entry $473.72·now $526.23

+11.08%

since Jun 13

PQUS · Weight increase · 2d

The weight of TMO within the PQUS ETF shifted with a pattern of two consecutive daily increases, moving from 0.29% to 0.30% on May 29th, and further to 0.32% on May 30th, following several days of stability at the 0.29% level. This measured progression aligns with Pictet Asset Management's stated approach for PQUS, which uses an AI ranking system for US large caps and executes periodic, rather than daily, rebalances with measured turnover. The AI system for PQUS likely interpreted TMO's recent price depreciation—a -22.6% 90-day return placing its current $492.51 at 77% of its 52-week high—as an opportune entry point. Despite this short-term decline, TMO maintains a 1-year return of +19.5% and shows financial metrics like a 13.24% ROE and 5.36% revenue growth, suggesting its underlying health remains attractive for an AI system managing a sector-balanced portfolio of approximately 165 US large-cap stocks.

weight 0.290% → 0.320% (+0.030 pp)·stock up 5.6% in the 30 days before

May 30·entry $494.04·now $526.23Drifting

+6.52%

since May 30

AIEQno longer held1 signal

AIEQ · Exit · 1d

The AI ETF likely divested TMO due to a rapid shift in short-term quantitative signals, potentially indicating a loss of momentum or less attractive relative valuation compared to other opportunities identified by its algorithm. For retail investors, this illustrates that AI funds make dynamic, often short-term tactical decisions, emphasizing the importance of understanding your own investment thesis and time horizon rather than blindly mimicking swift, algorithm-driven moves.

weight 0.230% → 0 (exited)·stock down 5.1% in the 30 days before

May 3·entry $462.60·now $526.23

+13.75%

since May 3

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.